Damoun Safarpour

297 posts

Damoun Safarpour

Damoun Safarpour

@HemeoncF

Hematologist and oncologist with stage IV mCRC!! community based. checking new research about MSS mCRC and KRAS G12D targeted therapies.

Katılım Nisan 2022
148 Takip Edilen117 Takipçiler
Damoun Safarpour
Damoun Safarpour@HemeoncF·
Remembering my husband Damoun, who passed from colon cancer in June 2025 at age 44. I am raising funds in his memory to support early screenings, save lives, and continue to keep his memory alive. impact.ccalliance.org/fundraiser/698…
English
0
0
1
96
Damoun Safarpour
Damoun Safarpour@HemeoncF·
We need to do better for IMGs. It’s not just about allowing them to practice—it’s about making sure they’re supported and treated with the respect they deserve.
English
0
1
3
226
Damoun Safarpour
Damoun Safarpour@HemeoncF·
The stress, the poor treatment, and the lack of real educational support took a toll. I truly believe it contributed to his illness at such a young age.
English
1
1
3
250
Damoun Safarpour
Damoun Safarpour@HemeoncF·
I came across a post saying that in some states, foreign-trained doctors may soon be able to practice without completing U.S. training or exams. It made me think of Damoun. I met Damoun on his first day of PGY-2.
English
1
1
5
287
Damoun Safarpour retweetledi
Pashtoon Kasi MD, MS
Pashtoon Kasi MD, MS@pashtoonkasi·
🆕🗞️Hot off the press! @NatureMedicine #KRAS Vaccine💉for patients with RAS➕cancers🎯. Benefit➡️durable.🙌🏽 More to come with the randomized study📚✔️! Opens to doors to off the shelf vaccine for so many patients with KRAS/NRAS mutations. @OncoAlert 🔗nature.com/articles/s4159…
Pashtoon Kasi MD, MS tweet media
English
8
100
231
17.3K
Damoun Safarpour
Damoun Safarpour@HemeoncF·
@illium51 @pashtoonkasi @NatureMedicine @OncoAlert @PanCAN @oncodaily @oncologytube @OncLive @MPishvaian @ShaalanBeg @cancerassassin1 @FightCRC @CCAlliance @colontown It’s not about giving up; it’s about navigating a reality that no amount of training or strength can fully prepare you for.I hope that in the future we’ll be able to convert stage IV into MRD, but I’m not sure I’ll see that in my lifetime. Btw my husband was the owner of this acc
English
1
0
1
60
Damoun Safarpour
Damoun Safarpour@HemeoncF·
@illium51 @pashtoonkasi @NatureMedicine @OncoAlert @PanCAN @oncodaily @oncologytube @OncLive @MPishvaian @ShaalanBeg @cancerassassin1 @FightCRC @CCAlliance @colontown They are vita, but when you are stage IV and go to centers like MD Anderson or MSKCC and they don’t offer any aggressive therapies and/or consolidative techniques because of the “bad biology of the cancer”, then where should you and how should you convert more patients to MRD?
English
1
0
0
74
Adam N
Adam N@Scooter0732·
@Foxhound131 @HemeoncF Pts like Damoun who no longer are eligible for trials ~~> access to immediate compassionate use. Protections for companies that encourages and incentivizes. Tax breaks, faster review times, firewall CU data (so it doesn’t count as strike against them), and liability protection.
English
1
0
1
47
Damoun Safarpour
Damoun Safarpour@HemeoncF·
Damoun was exploring compassionate care options when we found a promising medication that could help with lymphangitic carcinomatosis. The company declined access, and he couldn’t join the trial. I emailed after he passed.
English
2
2
4
409
Adam N
Adam N@Scooter0732·
@Foxhound131 @HemeoncF Carve outs in the data causes further manipulation of said data. Not an easy problem to solve…
English
2
0
0
69
Damoun Safarpour
Damoun Safarpour@HemeoncF·
@Foxhound131 @Scooter0732 I get it too… they are many risks that come with drugs being tested however there should be some power in informed consent… I am not sure if has anything to do with FDA as companies set the rules if they want to give the drug out or not
English
0
0
0
23
Michael
Michael@Foxhound131·
@Scooter0732 @HemeoncF I totally get why they don’t do it, but that’s a bigger systemic issue. There should be carve outs for the data, FDA needs to acknowledge that they are incentivizing limiting compassionate use
English
2
0
0
36